home / stock / ibrx / ibrx quote
Last: | $8.97 |
---|---|
Change Percent: | -2.11% |
Open: | $8.72 |
Close: | $8.97 |
High: | $9.12 |
Low: | $8.25 |
Volume: | 8,528,160 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.97 | $8.72 | $8.97 | $9.12 | $8.25 | 8,528,160 | 05-02-2024 |
$8.54 | $7.94 | $8.54 | $8.99 | $7.45 | 12,684,885 | 05-01-2024 |
$7.99 | $8.88 | $7.99 | $9.39 | $7.9 | 15,004,108 | 04-30-2024 |
$8.99 | $8.41 | $8.99 | $10.53 | $8.12 | 66,104,815 | 04-29-2024 |
$7.35 | $5.11 | $7.35 | $7.74 | $4.9201 | 40,280,221 | 04-26-2024 |
$5.11 | $5.06 | $5.11 | $5.175 | $4.82 | 8,556,026 | 04-25-2024 |
$4.82 | $5.43 | $4.82 | $5.72 | $4.79 | 7,855,183 | 04-24-2024 |
$5.49 | $6.15 | $5.49 | $6.19 | $4.84 | 30,589,809 | 04-23-2024 |
$4.94 | $5.27 | $4.94 | $5.35 | $4.92 | 5,468,509 | 04-22-2024 |
$5.27 | $4.91 | $5.27 | $5.305 | $4.82 | 4,571,786 | 04-19-2024 |
$4.91 | $5.09 | $4.91 | $5.28 | $4.91 | 3,516,802 | 04-18-2024 |
$5.24 | $5.09 | $5.24 | $5.425 | $4.765 | 4,754,958 | 04-17-2024 |
$4.92 | $5.12 | $4.92 | $5.1202 | $4.85 | 2,879,745 | 04-16-2024 |
$5.24 | $5.15 | $5.24 | $5.55 | $4.93 | 3,844,244 | 04-15-2024 |
$5.11 | $6.05 | $5.11 | $6.0945 | $4.73 | 6,881,878 | 04-12-2024 |
$6.06 | $6.01 | $6.06 | $6.26 | $5.9588 | 3,349,679 | 04-11-2024 |
$5.96 | $5.985 | $5.96 | $6.13 | $5.7325 | 4,355,450 | 04-10-2024 |
$6.16 | $6.2 | $6.16 | $6.33 | $5.97 | 3,397,135 | 04-09-2024 |
$6.17 | $5.75 | $6.17 | $6.18 | $5.5899 | 3,204,763 | 04-08-2024 |
$5.71 | $5.62 | $5.71 | $5.86 | $5.48 | 3,308,058 | 04-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
ImmunityBio Inc. Company Name:
IBRX Stock Symbol:
NASDAQ Market:
Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatment for non-muscle invasive bladder cancer (NMIBC) Serum Institute of India (SII) will manufacture both standard BCG (“sBCG”) and n...
Dr. Sam S. Chang, Professor of Urology at Vanderbilt Cancer Program, to host the program “A Deep Dive with Patrick Soon-Shiong: Next-Generation Immunotherapy for NMBIC” Discussion about the basis for ANKTIVA’s Breakthrough Therapy designation and the novel mechanism o...
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily ...